Pernix Sleep Stock Price, News & Analysis (NASDAQ:SOMX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Pernix Sleep (NASDAQ:SOMX)

Pernix Sleep logoPernix Sleep Inc, formerly Somaxon Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. The Company operates in one segment, which is the development and commercialization of pharmaceutical products. The Company's focus is on commercial activities relating to Silenor. As of December 31, 2011, the clinical development program for Silenor included four Phase III clinical trials. In June 2011, it entered into agreements with Paladin Labs Inc. (Paladin), under which Paladin had the right to commercialize Silenor in Canada, South America, the Caribbean and Africa, subject to the receipt of marketing approval in each such territory. In March 2013, Pernix Therapeutics Holdings Inc acquired the Company.

Receive SOMX News and Ratings via Email

Sign-up to receive the latest news and ratings for SOMX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Pernix Sleep (NASDAQ:SOMX) Frequently Asked Questions

What is Pernix Sleep's stock symbol?

Pernix Sleep trades on the NASDAQ under the ticker symbol "SOMX."

Who are some of Pernix Sleep's key competitors?

Has Pernix Sleep been receiving favorable news coverage?

Media headlines about SOMX stock have trended somewhat positive on Monday, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Pernix Sleep earned a news sentiment score of 0.19 on Accern's scale. They also gave headlines about the specialty pharmaceutical company an impact score of 45.61 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Pernix Sleep?

Shares of SOMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Pernix Sleep?

Pernix Sleep's mailing address is 440 Stevens Ave Ste 200, SOLANA BEACH, CA 92075-2059, United States. The specialty pharmaceutical company can be reached via phone at +1-302-6587581.

MarketBeat Community Rating for Pernix Sleep (SOMX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about Pernix Sleep and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pernix Sleep (NASDAQ:SOMX) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Pernix Sleep (NASDAQ:SOMX) Earnings History and Estimates Chart

Earnings by Quarter for Pernix Sleep (NASDAQ:SOMX)

Pernix Sleep (NASDAQ SOMX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2012Q3 2012($0.35)($0.36)ViewN/AView Earnings Details
8/7/2012Q2 2012($0.24)($0.37)ViewN/AView Earnings Details
5/10/2012Q1 2012($0.32)($0.35)ViewN/AView Earnings Details
3/8/2012Q4 2011($1.68)($1.71)ViewN/AView Earnings Details
11/3/2011Q3 2011($2.48)($2.86)ViewN/AView Earnings Details
8/2/2011Q2 2011($2.88)($2.63)ViewN/AView Earnings Details
5/3/2011Q1 2011($2.80)($3.03)ViewN/AView Earnings Details
3/3/2011Q4 2010($3.20)($3.36)ViewN/AView Earnings Details
11/9/2010Q3 2010($3.20)($2.93)ViewN/AView Earnings Details
8/11/2010Q2 2010($0.88)($1.31)ViewN/AView Earnings Details
5/11/2010Q1 2010($0.56)($1.30)ViewN/AView Earnings Details
3/18/2010Q4 2009($0.64)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.64)ViewN/AView Earnings Details
8/6/2009Q2 2009($1.76)($2.64)ViewN/AView Earnings Details
5/7/2009Q1 2009($2.24)($1.98)ViewN/AView Earnings Details
3/12/2009Q4 2008($3.92)($4.14)ViewN/AView Earnings Details
11/6/2008Q3 2008($4.32)($4.51)ViewN/AView Earnings Details
8/7/2008Q2 2008($3.28)($4.54)ViewN/AView Earnings Details
5/6/2008Q1 2008($2.80)($3.10)ViewN/AView Earnings Details
3/11/2008Q4 2007($2.64)($3.42)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Pernix Sleep (NASDAQ:SOMX) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Pernix Sleep (NASDAQ:SOMX)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Pernix Sleep (NASDAQ SOMX)

No insider trades for this company have been tracked by


Pernix Sleep (NASDAQ SOMX) News Headlines

No headlines for this company have been tracked by

SEC Filings

Pernix Sleep (NASDAQ:SOMX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Pernix Sleep (NASDAQ:SOMX) Income Statement, Balance Sheet and Cash Flow Statement


Pernix Sleep (NASDAQ SOMX) Stock Chart for Monday, March, 19, 2018

Loading chart…

This page was last updated on 3/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.